Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2020

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • K Offline
    K Offline
    KWC
    wrote on sidst redigeret af
    #520

    Nej åbningskurs solsen

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #521

      Tak for ellers var der sket noget meget hurtigt med Novod.

      1 Reply Last reply
      0
      • Legolas23L Offline
        Legolas23L Offline
        Legolas23
        wrote on sidst redigeret af
        #522

        Det ligner en åbning i 1750

        1 Reply Last reply
        0
        • O Offline
          O Offline
          OHW
          wrote on sidst redigeret af
          #523

          enmab/DNB: Kursmålet løftes til 1750 kr.

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #524

            Den meget nært forestående partneraftale vil tiltrække kortsigtede investorer.

            1 Reply Last reply
            0
            • DarvinD Offline
              DarvinD Offline
              Darvin
              wrote on sidst redigeret af
              #525

              Han skal bare have et nyt solstik, så ændres alt

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gentogen
                wrote on sidst redigeret af
                #526

                Jan talte om et Covid-19 hold i rekruttering, som jeg hørte det

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #527

                  Ok

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #528

                    Nu 1770 😉

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #529

                      Måske toppen i dag

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #530

                        And we will not actually let the coronavirus troubles hinder that because we actually think that we can turn this era into an advantage potentially for Genmab and for the partner for epcoritamab because we know that some of the large Phase III trials from competing programs like the Roche CD20 -- CD3/CD20 bispecific programs are on hold right now, whereas we are still recruiting patients and planning new studies

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #531

                          Så blev vi så meget klogere på hjemmeadministration. :-). Sikkert fremprovokeret af covid 19. Det er bedre at sende en sygeplejerske ud, som er erfaren med beskyttelse, end at få en potentiel smittebærer ind. Og det er jo ikke sikkert, at det vil foregå hjemme allerede fra 1. injektion pga observation.

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            kkjoel
                            wrote on sidst redigeret af
                            #532

                            gentogen, 09:00 - ikke for så vidt angår epcoritamab i hvert fald: "And what is also good, Michael, is that despite the challenges, of course, of recruiting patients in this COVID-19 era, I can tell you that the doctors have been very, very enthusiastic about moving patients into this study, this Phase I/II study."

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              kkjoel
                              wrote on sidst redigeret af
                              #533

                              Og senere: "And we will not actually let the coronavirus troubles hinder that because we actually think that we can turn this era into an advantage potentially for Genmab and for the partner for epcoritamab because we know that some of the large Phase III trials from competing programs like the Roche CD20 -- CD3/CD20 bispecific programs are on hold right now, whereas we are still recruiting patients and planning new studies."

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                kkjoel
                                wrote on sidst redigeret af
                                #534

                                Ahh, duee fanme'
                                hurtig Solsen 🙂

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #535

                                  Det er kursen også. Mon vi skal ramme 1800 i dag.

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    kkjoel
                                    wrote on sidst redigeret af
                                    #536

                                    Tør jeg mon gentage spørgsmålet fra i nat: "Hvorfor understreger Jan igen og igen, at de vil have US commercial rights/co-promotion - det er vel lige meget hvem af partnerne der sælger hvor og hvor meget... når man alligevel, ved dagens slutning, deler pengene?!

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #537

                                      Præcis det jeg mente. Jan fik det talt op som en potentiel fordel for Genmab, at Roche har rekrutteringsproblemer, mens Genmab ikke oplever det (i CD3/CD20)

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #538

                                        Er det først og fremmest
                                        synlighed for GEN.. med det lange sigte om "Iconic company"?

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #539

                                          Yes, gentogen - jeg mislæste dit sætning.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger